Melbourne Haematology

Dr Simon He
All Appointments and Enquiries:
Tel: 03 9063 1165
Fax: 03 8677 5489

(NEW: Main rooms)
Epworth Eastern Hospital

Suite 10.3, Level 10, East Wing Tower
Epworth Eastern Hospital
(opposite to Box Hill RSL)
1 Arnold Street
Box Hill, VIC 3128

View Map of Room's Location

Private Hospital Accreditations
Epworth Eastern Hospital
Knox Private Hospital
Epworth Eastern Richmond
Ringwood Private Hospital
Mitcham Private Hospital
pager : 03 9387 1000
(after hours)
for all urgent referrals
email : This email address is being protected from spambots. You need JavaScript enabled to view it.

---

MBBS FRACP FRCPA

• Consultant Haematologist

Simon Zhao-Xiong He was born in Guangzhou and graduated from medicine from the University of Melbourne in 1998. Since 2007, Dr He has become a joint fellow in colleges of Pathologists and Physicians specialising in laboratory and clinical haematology.

Dr He was awarded Haematology and Bone Marrow Transplant fellowship at The Royal Melbourne Hospital (RMH) in 2007 and the Max Whiteside Clinical Fellowship by Leukaemia Foundation in 2008.

Dr He was appointed as the medical lead in bone marrow transplant stream at Olivia Newton-John Cancer, Wellness and Research Centre at Austin Hospital in 2016 and also works as bone marrow transplant physician at Victorian Comprehensive Cancer Centre (VCCC) in Melbourne.

Dr He undertook clinical research in acute myeloid leukaemia, chronic lymphocytic leukaemia, autoimmune disorders and chronic graft-vs-host disease. Other major areas of interest include bone marrow transplantation and chronic myeloid leukaemia.

Simon also speaks fluent Cantonese and Mandarin.

Dr He undertook clinical research in acute myeloid leukaemia, chronic lymphocytic leukaemia, autoimmune disorders and chronic graft-vs-host disease. Other major areas of interest include bone marrow transplantation and chronic myeloid leukaemia.

NOTE:
For All Appointments and Enquiries for Dr Simon He:
Telephone (Reception): 03 9063 1165
Fax: 03 8677 5489

POSTAL ADDRESS:
PO Box 340
Mont Albert VIC 3127

ADMINISTRATIVE EMAIL: This email address is being protected from spambots. You need JavaScript enabled to view it.

Selected Publications

1. He Simon et al. A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia, Leukemia & Lymphoma. 2015;56:5, 1406-15.
2. Roberts AW et al, Substantial susceptibility of Chronic Lymphocytic Leukemia to BCL2 inhibition:Results of phase 1 study of navitoclax (ABT-263) in patients with relapsed or refractory disease, J Clin Oncol. 2012 Feb 10;30(5):488-96. Epub 2011 Dec 19
3. Batzios C, Hayes L, He S, Quach H, McQuilten Z, Wall M, and Campbell LJ. Secondary Cytogenetic Abnormalities Following Successful Treatment of Acute Promyelocytic Leukemia. Am J Hematol. 2009 Nov;84(11):715-9.
4. He S. and Roberts AW. Targeted Therapies in Haematological Malignancies. Cancer Forum 2008;32:163-7
5. He S. et al. Prospective study of abbreviated course rituximab for autoimmune haematological disorders refractory to standard immunosuppressive therapy. Abstract (no.1028), the 14th Congress of the European Hematology Association

Society Memberships

• American Society of Hematology (ASH)
• Haematology Society of Australia & New Zealand (HSANZ)
• Australasian Leukaemia and Lymphoma Group (ALLG)